Oncology Market In India 2026-2030
Description
Oncology Market In India 2026-2030
The oncology market in india is forecasted to grow by USD 2359.5 mn during 2025-2030, accelerating at a CAGR of 20.0% during the forecast period. The report on the oncology market in india provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cancer incidence and growing disease awareness, expansion of oncology healthcare infrastructure and specialized treatment centers, increasing adoption of advanced therapies and pharmaceutical innovation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's oncology market in india is segmented as below:
By Type
The report on the oncology market in india covers the following areas:
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
The oncology market in india is forecasted to grow by USD 2359.5 mn during 2025-2030, accelerating at a CAGR of 20.0% during the forecast period. The report on the oncology market in india provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cancer incidence and growing disease awareness, expansion of oncology healthcare infrastructure and specialized treatment centers, increasing adoption of advanced therapies and pharmaceutical innovation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's oncology market in india is segmented as below:
By Type
- Cancer treatment
- Cancer diagnostics
- Hospitals
- Diagnostic laboratories
- Diagnostic imaging centers
- Others
- Breast cancer
- Lung cancer
- Blood cancer
- Colorectal cancer
- Others
- Asia
The report on the oncology market in india covers the following areas:
- Oncology market in india sizing
- Oncology market in india forecast
- Oncology market in india industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
195 Pages
- Market overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Criticality of inputs and Factors of differentiation
- Factors of disruption
- Impact of drivers and challenges
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2025
- Market outlook: Forecast for 2025-2030
- Oncology Market in India 2020 - 2024
- Type segment analysis 2020 - 2024
- End-user segment analysis 2020 - 2024
- Disease Type segment analysis 2020 - 2024
- Impact of AI in oncology market in India
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segments
- Comparison by Type
- Cancer treatment - Market size and forecast 2025-2030
- Cancer diagnostics - Market size and forecast 2025-2030
- Market opportunity by Type
- Market segments
- Comparison by End-user
- Hospitals - Market size and forecast 2025-2030
- Diagnostic laboratories - Market size and forecast 2025-2030
- Diagnostic imaging centers - Market size and forecast 2025-2030
- Others - Market size and forecast 2025-2030
- Market opportunity by End-user
- Market segments
- Comparison by Disease Type
- Breast cancer - Market size and forecast 2025-2030
- Lung cancer - Market size and forecast 2025-2030
- Blood cancer - Market size and forecast 2025-2030
- Colorectal cancer - Market size and forecast 2025-2030
- Others - Market size and forecast 2025-2030
- Market opportunity by Disease Type
- Customer landscape overview
- Market drivers
- Market challenges
- Impact of drivers and challenges
- Market opportunities
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
- Companies profiled
- Company ranking index
- Market positioning of companies
- Abbott Laboratories
- Alkem Laboratories Ltd.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GE Healthcare Technologies
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Merck and Co. Inc.
- Natco Pharma Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
- Scope of the report
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
